University of Michigan Health System expands Mobile Aspects tissue tracking solution into pediatric surgical areas

NewsGuard 100/100 Score

Mobile Aspects announced today that the University of Michigan Health System has signed an agreement to expand the use of its tissue tracking solution into the Operating Room at the University of Michigan C.S. Mott Children’s Hospital. The solution, called iRISecure™, uses the unique characteristics of radio frequency identification (RFID) technology to automate clinical workflow associated with tissue tracking. In turn, a powerful solution is delivered to help care providers comply with process and procedural requirements from The Joint Commission and U.S. Food and Drug Administration (FDA) for the utilization of tissue and related products.

“We look forward to expanding the Mobile Aspects tissue tracking solution into our pediatric surgical areas”

The solution will be deployed to manage the receipt, storage and utilization of implantable tissue and related products used for surgical procedures at the University of Michigan C. S. Mott Children’s Hospital. The tissue tracking solution has been used within the Operating Rooms Department at the University Hospital for over a year.

“We look forward to expanding the Mobile Aspects tissue tracking solution into our pediatric surgical areas,” commented Patricia Silverman, Business Systems Leader for the Operation Rooms. “Through its use of RFID technology, the solution delivers a simple to use system for our busy clinical staff that creates a highly automated process to help us manage our tissue effectively.”

To demonstrate the capabilities of iRISecure and other solutions used in the perioperative care setting, Mobile Aspects will be exhibiting at the 57th Annual Congress for the Association of periOperative Registered Nurses (AORN). The event exhibition will be held March 15-17 in Denver, Colorado.

Source:

Mobile Aspects, Inc.,

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers find new clues to understanding the progression of primary membranous nephropathy